Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2026-01-02 @ 10:11 PM
Study NCT ID:
NCT04168203
Status:
COMPLETED
Last Update Posted:
2025-11-14
First Post:
2019-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism
Sponsor:
Brigham and Women's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2019-11-12
First Submit QC Date:
None
Study First Post Date:
2019-11-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-09-15
Results First Submit QC Date:
None
Results First Post Date:
2025-09-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-01
Last Update Post Date:
2025-11-14
Last Update Post Date Type:
ESTIMATED